Cargando…
Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature
Direct oral anticoagulants can potentially provide a more convenient oral alternative for the management of left ventricular thrombi than Warfarin. These medications do not require frequent monitoring and have less drug‐drug interactions. Randomized controlled trials are needed to further demonstrat...
Autores principales: | Shokr, Mohamed, Ahmed, Abdelrahman, Abubakar, Hossam, Sayedahmad, Ziad, Rashed, Ahmed, Afonso, Luis, Cardozo, Shaun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332814/ https://www.ncbi.nlm.nih.gov/pubmed/30656027 http://dx.doi.org/10.1002/ccr3.1917 |
Ejemplares similares
-
Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?
por: Garg, Rimmy, et al.
Publicado: (2022) -
Direct Oral Anticoagulants vs Vitamin K Antagonists in Left Ventricular Thrombi: A Systematic Review and Meta-analysis
por: Michael, Faith, et al.
Publicado: (2021) -
Large Mobile Left Ventricular Thrombi Formation in a 32-Year-Old Despite Direct Oral Anticoagulation With Dabigatran
por: Weberling, Lukas Damian, et al.
Publicado: (2022) -
The role of rivaroxaban in left ventricular thrombi
por: Abdelnaby, Mahmoud, et al.
Publicado: (2019) -
Subacute Right Ventricular Perforation by Pacemaker Lead Causing Left-Sided Hemothorax and Epicardial Hematoma
por: Ahmed, Abdelrahman, et al.
Publicado: (2017)